Apotex Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013558
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor and Winnipeg. It has manufacturing and distribution facilities across the world and offers its products to patients, healthcare providers and payers, governments and other pharmaceutical manufacturers the world over. It operates through subsidiaries, joint ventures and licensing agreements in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Apotex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Licensing Agreements 12
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Acquisition 16
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc – Key Competitors 17
Apotex Inc – Key Employees 18
Apotex Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Legal and Regulatory 21
Oct 03, 2016: Apotex Files Lawsuit Seeking Compensation for “Improper” Government Actions 21
Other Significant Developments 22
Mar 08, 2017: Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Apotex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Apotex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Apotex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Apotex Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Apotex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Charterhouse Capital Partners Acquires Doc Generici For US$424 Million 10
Panacea Biotec Expands Licensing Agreement with Apotex 12
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 13
Cangene Enters Into Licensing Agreement With Apotex For Biotech Drugs 15
Apotex Acquires Aveva Drug Delivery Systems From Nitto Denko 16
Apotex Inc, Key Competitors 17
Apotex Inc, Key Employees 18
Apotex Inc, Subsidiaries 19

★海外企業調査レポート[Apotex Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Irish Life Assurance plc:企業の戦略・SWOT・財務分析
    Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fidelity National Financial Inc:企業の戦略・SWOT・財務情報
    Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Netsmart Technologies Inc:企業の戦略的SWOT分析
    Netsmart Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Tosoh Corporation:企業の戦略・SWOT・財務分析
    Tosoh Corporation - Strategy, SWOT and Corporate Finance Report Summary Tosoh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software solutions. The company offers embedded technologies, testing and validation, certifications, software outsourcing, research and development centers, professional staffing and packaged services. It offers realtime operating system …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It also provides discovery chemistry, discovery biology, large molecule development, safety assess …
  • Biosensors International Group Ltd:企業の戦略的SWOT分析
    Biosensors International Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Luna Innovations Inc (LUNA):医療機器:M&Aディール及び事業提携情報
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Ficosa International SA:企業の戦略・SWOT・財務情報
    Ficosa International SA - Strategy, SWOT and Corporate Finance Report Summary Ficosa International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Trammo Inc:企業の戦略的SWOT分析
    Trammo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • GCL-Poly Energy Holdings Ltd (3800):電力:M&Aディール及び事業提携情報
    Summary GCL-Poly Energy Holdings Limited (GCL) is a solar energy holding company. Through its subsidiaries, associates and joint ventures, the company produces polysilicon and supplies silicon wafer. It also provides integrated solar system solutions covering project development, design, procurement …
  • Van Lanschot Private Banking:企業の戦略・SWOT・財務情報
    Van Lanschot Private Banking - Strategy, SWOT and Corporate Finance Report Summary Van Lanschot Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Emerson Electric Co (EMR):電力:M&Aディール及び事業提携情報
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • ProSciento Inc-医療機器分野:企業M&A・提携分析
    Summary ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that concentrates on developing drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development an …
  • Saudi Electricity Co:発電所・企業SWOT分析
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析
    Summary Institut Gustave Roussy (IGR) is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provides treatment for the diseases that include endocrine tumours, childhood cancer, gynecological ca …
  • AC Immune SA (ACIU):企業の財務・戦略的SWOT分析
    AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • 3i Group Plc:企業の戦略・SWOT・財務情報
    3i Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3i Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆